At the IGTP TODAY
An article published in Nature Communications on the pilot study carried out in Catalonia to evaluate the self-collection of biological samples reveals the high acceptability of the proposal and the key role of diagnosis in people without symptoms of mpox.
A study has identified a molecule that could potentially be a target for the development of immunotherapies, led by IrsiCaixa AIDS Research Institute and spearheaded by Julia García-Prado, principal investigator at the same centre and scientific director of the Germans Trias i Pujol Research Institute (IGTP).
The collaborative project InMaM, part of the Complementary Plan for Biotechnology Applied to Health, involving both Catalonia and the Basque Country, aims to discover new immunotherapy-based treatments for metastatic breast cancer.
A study co-led by researchers from IGTP, IIB Sant Pau and IDIBGI concludes that direct transport to a referral centre for endovascular treatment may not be the best option for patients with a final diagnosis of intracerebral haemorrhage or haemorrhagic stroke.
A study published in Nature unveils new genetic insights into COVID-19 susceptibility and severity. This work marks a significant advancement in our understanding of the role genetics play in determining COVID-19 outcomes.
The Ibero-American network RIGHT PLUS, of which the CEEISCAT is a founding member and, together with Coalition Plus, co-coordinator, has presented its launch at a meeting in Buenos Aires (Argentina) on 28-29 August.
Dr Jordi Casabona spent a week on the island working directly with international organizations, ministries, hospitals, and civil society.
To mark World Hepatitis Day, the podcast 'Un Bri de Ciència' dedicates an episode to viral hepatitis, specifically focusing on Hepatitis B and C, which are considered to be the most severe types. Researcher Elisa Martró unravels what we know about these diseases and discusses her projects, both in the hospital setting and in communities, working with vulnerable populations. The podcast enhances the mission of awareness and dissemination of IGTP.
The certification body AENOR has accredited the Germans Trias i Pujol Research Institute (IGTP) for successfully implementing a research, development, and innovation (R&D&I) management system in accordance with the UNE 166002:2021 Standard. This certification is a guarantee of good practices, and confirms that the implementated R&D&I management system meets the statutory requirements.
